Understanding the Relationship Between Infliximab Levels to Clinical Response of Remicade in Crohn's Disease
Status:
Terminated
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to improve the investigators understanding of the relationship
between Crohn's disease and blood levels of the drug infliximab (Remicade). The investigators
want to determine whether measuring drug levels can be helpful in understanding how patients
respond to this treatment.